US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

703.16

+13.581.97%

Number of Gainers:47

Number of Losers:95

Number of Flat:11

PE:- -

High:707.24

Open:689.67

Low:689.64

Close:689.58

Volume:499.41M

Turnover:18.06B

Market Cap:485.23B

Float Cap:369.77B

Loading ...

Alpha Teknova participates in a conference call with Craig-Hallum

Alzamend Neuro Q1 FY27 Net Loss Narrows 12% to $3.03 Million

Robinhood Markets Shares Down 1.07% at $112.12 in Extended Trade After Reporting August Operating Data

THOMSON REUTERS

Lyell Immunopharma advances LYL273 CAR T program

TransCode Therapeutics Appoints John Tattory as Interim CFO

Duolingo Director William B. Gordon Sells USD 1.43 Million in Class a Common Stock

Ryan Specialty Names Dave Przesiek CEO of Ryan Specialty Benefits Unit

Candel Therapeutics Director Martine Zimmermann Files Initial Beneficial Ownership Statement

Coinbase Director Marc L Andreessen Disposes of 13,676 Shares Worth $2.48 Million

TransCode Therapeutics CFO Tom Fitzgerald Retires; John Tattory Named Interim CFO

Flywire General Counsel Peter Butterfield Disposes of Shares Worth $218,639.11

Transcode Therapeutics - Appoints John Tattory as Interim Chief Financial Officer Effective Immediately

THOMSON REUTERS

Transcode Therapeutics Announces Leadership Transition

THOMSON REUTERS

Press Release: TransCode Therapeutics Announces Leadership Transition

Lyell Immunopharma Expects 2027 FDA End-of-Phase 1 Meeting for Lyl273 Colorectal Cancer Trial

Robinhood Platform Assets Rise to $384 Billion at End-August 2026

Intapp CEO John T. Hall Disposes of $118,769 in Common Shares

Robinhood Markets, Inc. Reports August 2026 Operating Data

THOMSON REUTERS

Robinhood Markets, - Funded Customers at End of August 2026 were 28.6 Mln, up 1.90 Mln Year-over-Year

THOMSON REUTERS

Lyell Immunopharma, - Additional Clinical Data and End-of-Phase 1 FDA Meeting Expected in 2027

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/BK4539/news?page=23"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":703.16394,"timestamp":1789761599999,"preClose":689.5794,"halted":0,"volume":499414856,"delay":0,"changeRate":0.0197,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":13.584534,"latestTime":"09-18 16:00:00 EDT","open":689.67395,"high":707.24146,"low":689.6394,"amount":18064922513.199635,"amplitude":0.025526,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.238276,"peRate":114.534565,"turnoverRate":0.039081,"increases":47,"decrements":95,"flats":8,"marketCap":485234363991.625,"floatMarketCap":369774303250.875},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":707.24146,"amplitude":0.025526,"preClose":689.5794,"low":689.6394,"pbRate":"5.238276","latestPrice":703.16394,"volume":499414856,"delay":0,"open":689.67395,"prevYearClose":881.5255,"prevWeekClose":693.0266,"prevMonthClose":701.0681,"prevQuarterClose":742.922,"fiveDayClose":693.0266,"twentyDayClose":673.0297,"sixtyDayClose":707.541,"secType":"PLATE","market":"US","turnoverRate":0.039081,"peRate":114.534565,"marketCap":485234363991.625,"floatMarketCap":369774303250.875,"timestamp":1789761599999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":47,"down":95,"flat":11},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:23,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666516699","title":"Alpha Teknova participates in a conference call with Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2666516699","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666516699?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:50","pubTimestamp":1789073417,"startTime":"0","endTime":"0","summary":"Craig-Hallum holds a conference call with management on September 16 at 2 pm. Webcast Link Published first on TheFly – the ultimate source for real...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alpha-teknova-participates-in-a-conference-call-with-craig-hallum-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alpha-teknova-participates-in-a-conference-call-with-craig-hallum-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4121","TKNO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666426515","title":"Alzamend Neuro Q1 FY27 Net Loss Narrows 12% to $3.03 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666426515","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666426515?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:31","pubTimestamp":1789072315,"startTime":"0","endTime":"0","summary":"Alzamend Neuro Q1 FY27 net loss narrows 12% to $3.03 millionAlzamend Neuro posted a net loss of $3.03 million, widening 12% from a year earlier.Operating loss widened to $3.03 million as total operati","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL7zjjtz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ALZN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666154855","title":"Robinhood Markets Shares Down 1.07% at $112.12 in Extended Trade After Reporting August Operating Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2666154855","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666154855?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:29","pubTimestamp":1789072186,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL6N4521A3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HOOD","HOOY","BK4547","BK4539","HOYY","HOOC","ROBN","HOOW","BLCK","HOOI","FINX","IAI","BK4127","HOOZ","HOII","HODU","CRPT","BPAY","HOOG","HOOX","LU1861558580.USD","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666516839","title":"Lyell Immunopharma advances LYL273 CAR T program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666516839","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666516839?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:29","pubTimestamp":1789072155,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma ( ($LYEL) ) has issued an update. On September 10, 2026, Lyell Immunopharma announced it had completed the technology transfer f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lyell-immunopharma-advances-lyl273-car-t-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lyell-immunopharma-advances-lyl273-car-t-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LYEL","BK4505","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515120","title":"TransCode Therapeutics Appoints John Tattory as Interim CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515120","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515120?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:26","pubTimestamp":1789072010,"startTime":"0","endTime":"0","summary":"BRIEF-TransCode Therapeutics Appoints John Tattory As Interim CFOSept 10 (Reuters)-Transcode Therapeutics IncRNAZ.O:TRANSCODE THERAPEUTICS ANNOUNCES LEADERSHIP TRANSITIONTRANSCODE THERAPEUTICS - TOM F","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA5KVHNF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515162","title":"Duolingo Director William B. Gordon Sells USD 1.43 Million in Class a Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515162","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515162?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:23","pubTimestamp":1789071825,"startTime":"0","endTime":"0","summary":"Duolingo director William B. Gordon sells USD 1.43 million in Class A common stockDuolingo director William B. Gordon sold 10,000 Class A common shares on Sep. 8, 2026 at $143.83-$151.64.Holdings fell","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLbQT3M9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Duolingo Director William B. Gordon Sells USD 1.43 Million in Class a Common Stock","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DUOL","BK4539","BK4613","DUOG","BK4588","BK4204","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515154","title":"Ryan Specialty Names Dave Przesiek CEO of Ryan Specialty Benefits Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515154","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515154?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:22","pubTimestamp":1789071757,"startTime":"0","endTime":"0","summary":"Ryan Specialty names Dave Przesiek CEO of Ryan Specialty Benefits unitRyan Specialty named Dave Przesiek president and CEO of Ryan Specialty Benefits, effective immediately.Przesiek joined the benefit","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL1p2N6w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4173","RYAN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515151","title":"Candel Therapeutics Director Martine Zimmermann Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515151","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515151?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:22","pubTimestamp":1789071742,"startTime":"0","endTime":"0","summary":"Candel Therapeutics director Martine Zimmermann files initial beneficial ownership statementMartine Zimmermann filed an initial Form 3 as a director of Candel Therapeutics on Sept. 8, 2026.Disclaimer:","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL259g1Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","CADL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666051561","title":"Coinbase Director Marc L Andreessen Disposes of 13,676 Shares Worth $2.48 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666051561","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666051561?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:18","pubTimestamp":1789071522,"startTime":"0","endTime":"0","summary":"Coinbase director Marc L Andreessen disposes of 13,676 shares worth $2.48 millionCoinbase disclosed Director Marc L. Andreessen sold 13,676 Class A common shares on Sep. 8, 2026.The shares sold at a w","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL87BmYD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Coinbase Director Marc L Andreessen Disposes of 13,676 Shares Worth $2.48 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRPT","BITQ","LU1861220207.SGD","ICOI","DAPP","BK4585","07311","BK4600","BK4588","BKCH","BK4596","COIA","CONI","BK4516","COIO","COII","COYY","BK4595","07711","BK4554","FIAT","COIG","09311","LU1861558580.USD","COIX","09711","LU1861559042.SGD","IBLC","BK4539","FINX","BK4535","CONX","LU1861217088.USD","COIN","BLCK","FDIG","LU2360107671.USD","COIW","CONL","BK4112","BK4551","CONY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515837","title":"TransCode Therapeutics CFO Tom Fitzgerald Retires; John Tattory Named Interim CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515837","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515837?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:11","pubTimestamp":1789071074,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics CFO Tom Fitzgerald retires; John Tattory named interim CFOTransCode Therapeutics CFO Tom Fitzgerald retired. He resigned as CFO and as a director, effective immediately.John Tat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL6Z06gW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","WINT","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513093","title":"Flywire General Counsel Peter Butterfield Disposes of Shares Worth $218,639.11","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513093","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513093?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071028,"startTime":"0","endTime":"0","summary":"Flywire General Counsel Peter Butterfield disposes of shares worth $218,639.11Flywire General Counsel and CCO Peter Butterfield sold 12,156 shares of voting common stock on Sept. 8, 2026.Sale priced a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLbG2GVT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Flywire General Counsel Peter Butterfield Disposes of Shares Worth $218,639.11","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0757428866.USD","BK4539","BK4227","FLYW","LU1815336091.USD","BK4106","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513083","title":"Transcode Therapeutics - Appoints John Tattory as Interim Chief Financial Officer Effective Immediately","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513083","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513083?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA5KVHNF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513055","title":"Transcode Therapeutics Announces Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513055","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513055?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA5KVHNF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666156815","title":"Press Release: TransCode Therapeutics Announces Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2666156815","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666156815?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:10","pubTimestamp":1789071000,"startTime":"0","endTime":"0","summary":"Tom Fitzgerald, Chief Financial Officer, Announces his RetirementJohn Tattory, to become Interim Chief Financial OfficerBOSTON, Sept. 10, 2026 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNA","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513741","title":"Lyell Immunopharma Expects 2027 FDA End-of-Phase 1 Meeting for Lyl273 Colorectal Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513741","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513741?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:09","pubTimestamp":1789070965,"startTime":"0","endTime":"0","summary":"Lyell Immunopharma expects 2027 FDA End-of-Phase 1 meeting for LYL273 colorectal cancer trialLyell Immunopharma completed a manufacturing transfer for LYL273, its GCC-targeted CAR T-cell candidate for","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL5qVy37:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210150020.SGD","IE00BGHQF748.EUR","NDAQ","BK4585","LU2095319765.USD","BK4588","IE00BN0W2T93.GBP","BCDF","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","LYEL","BK4112","BK4139","IE00BQXX3F31.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","SG9999014039.USD","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014021.USD","IE00BN0W2W23.USD","BK4539","LU2210149790.SGD","BK4505","IE00B64PRP62.GBP","IE00BQXX3C00.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666051373","title":"Robinhood Platform Assets Rise to $384 Billion at End-August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666051373","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666051373?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:07","pubTimestamp":1789070872,"startTime":"0","endTime":"0","summary":"Robinhood platform assets rise to $384 billion at end-August 2026Robinhood reported August 2026 total platform assets of USD 384 billion, up 8% from July, up 26% year over year.Funded customers ended ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL3ykjNb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOOX","FINX","HOOZ","CRPT","HOOC","ROBN","BK4539","HOOD","BLCK","IAI","BK4127","HOYY","HOOG","LU1861559042.SGD","HOOW","LU1861558580.USD","HOOI","HODU","HOOY","BK4547","HOII","BPAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666137515","title":"Intapp CEO John T. Hall Disposes of $118,769 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666137515","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666137515?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:07","pubTimestamp":1789070865,"startTime":"0","endTime":"0","summary":"Intapp CEO John T. Hall disposes of $118,769 in common sharesIntapp CEO John T. Hall sold 3,000 common shares on Sep. 8 at a weighted-average USD 39.59.He exercised employee stock options for 3,000 sh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL8zsNKL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Intapp CEO John T. Hall Disposes of $118,769 in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","INTA","LU0757428866.USD","BK4023","BK4535","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666513451","title":"Robinhood Markets, Inc. Reports August 2026 Operating Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2666513451","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666513451?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:05","pubTimestamp":1789070701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA9CHMWF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HOOZ","HOOC","HOOG","ROBN","HOOI","BK4539","HOOY","CRPT","LU1861559042.SGD","BK4127","HOOD","FINX","BPAY","HOOW","BLCK","HODU","IAI","HOYY","BK4547","LU1861558580.USD","HOOX","HOII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666134085","title":"Robinhood Markets, - Funded Customers at End of August 2026 were 28.6 Mln, up 1.90 Mln Year-over-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2666134085","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666134085?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:05","pubTimestamp":1789070701,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA9CHMWF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HOII","HOOX","BK4539","HOOZ","HOOI","FINX","HOOC","HOOG","HOOW","HODU","ROBN","CRPT","BLCK","HOOY","IAI","LU1861558580.USD","BK4127","HOOD","HOYY","BK4547","LU1861559042.SGD","BPAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666470513","title":"Lyell Immunopharma, - Additional Clinical Data and End-of-Phase 1 FDA Meeting Expected in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2666470513","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666470513?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:05","pubTimestamp":1789070701,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA6NT6LB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LYEL","BK4139","BK4539","BK4505"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":40,"pageCount":23,"totalSize":782,"code":"91000000","status":"200"}]}}